CORRECTION article

Front. Pharmacol., 20 October 2021

Sec. Pharmacology of Anti-Cancer Drugs

Volume 12 - 2021 | https://doi.org/10.3389/fphar.2021.785732

Corrigendum: Targeting Myc Interacting Proteins as a Winding Path in Cancer Therapy

  • 1. Zhejiang Province Key Laboratory of Anti-Cancer Drug Research, Institute of Pharmacology and Toxicology, College of Pharmaceutical Sciences, Zhejiang University, Hangzhou, China

  • 2. The Innovation Institute for Artificial Intelligence in Medicine, Zhejiang University, Hangzhou, China

  • 3. Cancer Center of Zhejiang University, Hangzhou, China

In the published article, there was an error regarding the Affiliation for Meng Yuan. Instead of “Cancer Center of Zhejiang University, Hangzhou, China,” the correct affiliation is “The Innovation Institute for Artificial Intelligence in Medicine, Zhejiang University, Hangzhou, China.”

The authors apologize for this error and state that this does not change the scientific conclusions of the article in any way. The original article has been updated.

Statements

Publisher’s note

All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.

Summary

Keywords

MYC, cancer therapy, interaction protein, transcriptional regulation, post-translational modification, inhibitors

Citation

Zhou Y, Gao X, Yuan M, Yang B, He Q and Cao J (2021) Corrigendum: Targeting Myc Interacting Proteins as a Winding Path in Cancer Therapy. Front. Pharmacol. 12:785732. doi: 10.3389/fphar.2021.785732

Received

29 September 2021

Accepted

30 September 2021

Published

20 October 2021

Approved by

Frontiers Editorial Office, Frontiers Media SA, Switzerland

Volume

12 - 2021

Updates

Copyright

*Correspondence: Qiaojun He, ; Ji Cao,

†These authors have contributed equally to this work

This article was submitted to Pharmacology of Anti-Cancer Drugs, a section of the journal Frontiers in Pharmacology

Disclaimer

All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.

Outline

Cite article

Copy to clipboard


Export citation file


Share article

Article metrics